According to an editorial, colchicine seems a promising novel treatment option for different cardiovascular applications beyond the well-established efficacy in acute and recurrent pericarditis. It notes that ongoing trials will soon provide additional evidence for or against a possible indication in acute and chronic ischaemic heart diseases, but there is a need for additional basic and clinical research to better understand the molecular mechanisms, and to verify the real efficacy of colchicine.